Products

By combination of CHEMI SPA experience in APIs manufacturing and of ITALFARMACO SPA competence in developing and manufacturing injectable products (i.e. Pre-Filled Syringes), today CHEMI is offering a pipeline of Finished Dosage Formulations and Dossiers for worldwide Licensing,

ITALFARMACO  Group is a primary Italian pharmaceutical Company specialized in Marketing & Sale of branded products and branded generics in Italy, Spain, France, Greece, Portugal, Russia and CIS, Chile, Switzerland, Turkey, where its own subsidiaries are present.

Pharmaceutical production plants are located in Spain (pharmaceutical oral liquids, monodose vials and multidose bottles) and Italy (pharmaceutical injectable Pre-Filled Syringes, and oral solids).

Starting from January 2016 ChemiPharma Ltd, a new facility dedicated to manufacture of sterile cytotoxic products (lyophilized or in solution) will operate in Malta.

Our APIs and Injectable Finished Dosage Formulations are fully developed and manufactured in facilities that are inspected, approved and accredited by many Health Authorities.

Our Dossiers are Generic and Generic Plus. Among these, we are able to offer our Pre-Filled Syringes, developed for products originally formulated/available in vials only.

  • Bendamustine 25 mg/VIAL, 100 mg/VIAL
  • Bortezomib 3.5 mg/VIAL
  • Bivalirudin 250 mg/VIAL
  • Eptifibatide 75 mg/100 mL, 200 mg/100 mL
  • Pemetrexed 500 mg BASE/VIAL, 100 mg BASE/VIAL
  • Decitabine 50 mg/VIAL o Azacitidine 100 mg/VIAL
  • Octreotide 0.2 mg/mL, 1 mg/mL

UNDER DEVELOPMENT

  • CyclophoSPAmide 500 mg/vial, 1 g/vial 2 g/vial
  • Melphalan 50 mg/vial
Products currently covered by valid Patents are offered for R&D purposes only
  • Octreotide 0.05 mg/1 mL, 0.1 mg/1 mL, 0.5 mg/1 mL
  • Zoledronic Acid 4 mg /5mL
  • Sodium Ibandronate 3 mg /3mL
  • Eptifibatide 20 mg/10 mL
  • Enoxaparin 20/0.2 mg/mL, 40/0.4 mg/mL, 60/0.6 mg/mL, 80/0.8 mg/mL, 100/1.0 mg/mL

UNDER DEVELOPMENT

  • Lanreotide 60 mg/0.2 mL, 90 mg/0.3 mL120 mg/0.5 mL, sterile, prefilled syringe
  • Exenatide 250mcg/mL
  • Exenatide , 2 mg/ pen
  • Icatibant 30mg/10 mL
Products currently covered by valid Patents are offered for R&D purposes only
  • Temozolomide cps 5 mg 20 mg 100 mg 140 mg 180 mg 250 mg
  • Pentosan polysulphate cps 100mg